Now showing items 1-5 of 5

    • Functional, cross-linked nanostructures for tandem optical imaging and therapy 

      Neumann, William L.; Dorshow, Richard B.; Freskos, John N.; Wooley, Karen L.; Lee, Nam S.; Lin, Yun; Sun, Guorong (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 5/30/2017)
      The present invention provides optical agents comprising optically functional cross linked supramolecular structures and assemblies useful for tandem optical imaging and therapy. Supramolecular structures and assemblies ...
    • Functional, cross-linked nanostructures for tandem optical imaging and therapy 

      Neumann, William L.; Dorshow, Richard B.; Freskos, John N.; Wooley, Karen L.; Lee, Nam S.; Lin, Yun; Sun, Guorong (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2016-03-29)
      The present invention provides optical agents comprising optically functional cross linked supramolecular structures and assemblies useful for tandem optical imaging and therapy. Supramolecular structures and assemblies ...
    • Functionalized protein-based materials and their uses 

      Bondos, Sarah; Bayless, Kayla; Matthews, Kathleen; Patterson, Jan; Abbey, Colette; Howell, David; Hsiao, Hao-Ching; Churion, Kelly; Tsai, Shang-Pu; Ramasamy, Sandhya; Porterpan, Dustin; Northern, Keira (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 3/16/2021)
      Embodiments of the invention are directed to Ubx-fusion molecules that maintain their mechanical strength and properties even after being fused with Ubx. Ubx fusions with VEGF and other growth factors, cell signaling ...
    • Method of treating endothelial dysfunction comprising administration of a thrombin peptide derivative 

      Carney, Darrell H.; Olszewska-pazdrak, Barbara; Fossum, Theresa W. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2012-12-18)
      Endothelial dysfunction (ED) is associated with a number of diseases and disorders. Agonists of the non-proteolytically activated thrombin receptor can be used in methods to treat ED or ED-related diseases and disorders.
    • Method of treating inflammatory bowel disease by administering a clip-inducing agent 

      Newell, Martha Karen; Harvey, Cassie L.; Tobin, Richard (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2014-12-09)
      The disclosure relates to methods for treating disorders of the mucosal tract such as the gastrointestinal system by targeting CLIP molecules. The methods are based on that CLIP in the groove of MHC class I or II molecules ...